The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2023

Filed:

Dec. 22, 2021
Applicant:

Thomas Julius Borody, Sydney, AU;

Inventor:

Thomas Julius Borody, Sydney, AU;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4164 (2006.01); A61K 31/65 (2006.01); A61K 31/4704 (2006.01); A61K 31/4174 (2006.01); A61K 31/341 (2006.01); A61K 31/422 (2006.01); A61K 31/426 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 45/06 (2006.01); A61K 31/42 (2006.01); A61K 31/47 (2006.01);
U.S. Cl.
CPC ...
A61K 31/65 (2013.01); A61K 31/341 (2013.01); A61K 31/4164 (2013.01); A61K 31/4174 (2013.01); A61K 31/42 (2013.01); A61K 31/422 (2013.01); A61K 31/426 (2013.01); A61K 31/47 (2013.01); A61K 31/4704 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); Y02A 50/30 (2018.01);
Abstract

There is disclosed herein a composition for treating extracellular parasitic infections, the composition comprising one or more of the following combinations: at least one quinolone or fluoroquinolone together with at least one tetracycline, iodoquinol, an azole or imidazole; or at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate. There is also disclosed herein a method for treating extracellular parasitic infections in a vertebrate in need of said treatment, wherein said treatment comprises administering to said vertebrate a therapeutically effective amount of (i) a composition comprising a quinolone or fluoroquinolone together with a pharmaceutically acceptable carrier or (ii) a composition of the invention or (iii) a combination of at least one quinolone or fluoroquinolone optionally together with at least one tetracycline, iodoquinol, an azole or imidazole; or (iv) a combination of at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate.


Find Patent Forward Citations

Loading…